1 Min Read
May 24 (Reuters) - Mabvax Therapeutics Holdings Inc
* Mabvax Therapeutics reports first quarter 2017 operational and financial results
* Q1 loss per share $0.85 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.